Arkolith/Insider Trading/MREO/Form 4

Pakianathan Deepika

DirectorMereo BioPharma Group plc (MREO) · full profile →Form 4 · filed Aug 23, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$466K
Net Open-Market Flow
-$466K
Transactions
13
7 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2024Option exercise(M)43K$0.94$41K103K
Aug 22, 2024Option exercise(M)2K$3.87$8K105K
Aug 22, 2024Option exercise(M)12K$2.72$34K21K
Aug 22, 2024Option exercise(M)39K$1.31$51K60K
Aug 22, 2024Option exercise(M)6K$1.84$12K8K
Aug 22, 2024Sell(S)105K$4.43$466K0
Aug 22, 2024Option exercise(M)2K$3.00$5K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 22, 2024Option exercise(M)55K—$00
Aug 22, 2024Option exercise(M)15K—$030K
Aug 22, 2024Option exercise(M)55K—$00
Aug 22, 2024Option exercise(M)32K—$00
Aug 22, 2024Option exercise(M)6K—$00
Aug 22, 2024Option exercise(M)11K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-100281) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML